Drug Shortage Report for BIO-ROSUVASTATIN

Last updated on 2022-01-31 History
Report ID 131512
Drug Identification Number 02444992
Brand name BIO-ROSUVASTATIN
Common or Proper name ROSUVASTATIN
Company Name BIOMED PHARMA
Market Status MARKETED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2021-01-13
Estimated end date
Actual end date 2022-01-30
Shortage status Resolved
Updated date 2022-01-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 9450 BOUL. LANGELIER
MONTREAL, QUEBEC
CANADA H1P 3H8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-01-31 English Compare
v5 2021-10-20 French Compare
v4 2021-10-20 English Compare
v3 2021-01-14 English Compare
v2 2021-01-13 French Compare
v1 2021-01-13 English Compare

Showing 1 to 6 of 6